JAZZ Venture Partners

Jazz Venture Partners, L.P. is a San Francisco-based venture capital firm founded in 2015, specializing in growth capital within the technology sector, particularly focusing on medical applications. The firm invests in companies that operate at the intersection of digital technology and neuroscience, emphasizing areas such as augmented reality, artificial intelligence, immersive gaming, and closed-loop human-computer systems. Jazz Venture Partners aims to support companies that leverage advanced brain science to enhance human performance across various markets, including health, wellness, education, sports, and entertainment. With a team comprising experienced investors, entrepreneurs, neuroscientists, and technologists, the firm possesses deep expertise and access to innovative companies, enabling it to effectively assist exceptional entrepreneurs in developing transformative businesses. Additionally, Jazz Venture Partners has offices in Santa Monica and Seattle, further broadening its strategic reach.

Stone Connell

Vice President of Finance

Sydney Cureton

Senior Associate

Sujude Dalieh

Senior Associate

Andrew Firlik

Co-Founder and Managing Partner

Narie Foster

Venture Partner

John Harris

Co-Founder and Managing Partner

Sharon Knight

Venture Partner

John Lee

Partner

Zack Lynch

Co-Founder and Managing Partner

Justin Nunez

Partner

Justin Nuñez

Partner

Meghan Reynolds

Venture Partner

John Spinale

Co-Founder and Managing Partner

Elan Tye

Principal

Amanda Way

Principal

Allison Williams

Principal

66 past transactions

JobGet

Series B in 2022
JobGet operates a mobile hiring application and job search platform designed to streamline the recruitment process, particularly in the retail and hospitality sectors. Founded in 2017 and based in Boston, Massachusetts, the platform facilitates direct communication between employers and job seekers, allowing them to message, schedule meetings, and conduct video interviews. By reducing the hiring timeline from weeks to mere minutes, JobGet aims to eliminate the lengthy traditional application process. The platform employs smart matching technology to connect thousands of job seekers with leading employers across the United States quickly and efficiently. JobGet has received recognition for its innovative approach, being a winner of the 2019 MassChallenge and the 2019 MIT Inclusive Innovation Challenge. Through its user-friendly interface, JobGet seeks to transform the employment landscape for hourly workers and employers, making job searching more accessible and immediate.

Oma Robotics

Venture Round in 2022
Oma Fertility is a full-service fertility clinic that offers fertility care and treatments. It brings top lab design and technology to in-house treatments like IUI and IVF, coordinates seamlessly with third parties like surrogate agencies and egg and sperm banks Oma uses Oma Sperm InSight and their proprietary AI microscope, which together help their embryologists select the most promising sperm cell for IVF.

Swing Therapeutics

Series A in 2022
Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.

KLOWEN Braces

Series A in 2022
KLOWEN Braces, Inc. is a company that specializes in the development of custom braces systems designed for orthodontists and their patients. Founded in 2019 and headquartered in Fort Collins, Colorado, KLOWEN utilizes a software platform to optimize the placement of uniquely shaped brackets for each tooth. The company's offerings include prefabricated, modular brackets that aim to straighten teeth more effectively and comfortably than traditional braces. In addition to these systems, KLOWEN provides various dental components such as brackets with hooks, bundles, tubes, and wires available for online purchase.

Colossal Biosciences

Series A in 2022
Colossal Biosciences is an innovative firm in the field of bioscience and genetic engineering, focused on advancing genomics technology. The company is dedicated to developing transformative solutions for the restoration of extinct species, protection of critically endangered species, and the repopulation of essential ecosystems. Utilizing CRISPR technology, Colossal aims to facilitate species de-extinction, starting with the woolly mammoth, thereby enabling environmental organizations to rehabilitate ecosystems and promote biodiversity. Through its efforts, Colossal seeks to address ecological challenges while also considering the economic and biological needs of humanity.

HerMD

Series A in 2022
HERmd is a provider of female comprehensive health, beauty, and wellness services. From gynecology and menopause to sexual medicine and medical aesthetics, the company provides a safe, trusted space to address all of the client's needs, no matter how personal. HERmd was founded by Somi Javaid in 2019 and is headquartered in Cincinnati, Ohio,

Augment AI

Seed Round in 2022
Augment AI supercharge productivity and enables to free from the minutiae.

Yumi

Series B in 2021
Yumi is a company that focuses on providing science-based meal delivery services for young children, aiming to help parents understand their children's nutritional needs. The company produces fresh, nutrient-dense, and low-sugar baby food products that cater to various age groups, ensuring that children receive adequate nutrition during their critical early years. In addition to baby food, Yumi offers vitamins designed to support brain development, making it a comprehensive resource for parents seeking healthy options for their children’s diets. Through its convenient meal delivery program, Yumi stands out as a leading choice for those prioritizing nutrition in early childhood.

Sounding Board

Series B in 2021
Sounding Board Labs, Inc. is a company that specializes in providing a coaching management platform aimed at enhancing leadership and managerial skills. Founded in 2016 and headquartered in Aliso Viejo, California, the platform delivers personalized development plans and connects users with qualified coaches via phone, video, and chat. Sounding Board’s technology integrates one-on-one coaching with scalable leadership development services, enabling organizations to implement coaching initiatives efficiently. The platform features automation tools for streamlined administration and robust data visualization capabilities to assess the overall impact of coaching on an enterprise-wide scale. With a focus on fostering productive leadership behaviors, Sounding Board serves global enterprises across 11 countries and has received a high Net Promoter Score, indicating strong client satisfaction.

AppliedVR

Series B in 2021
AppliedVR, Inc. specializes in virtual reality solutions aimed at enhancing patient experiences in healthcare, specifically for managing pain and anxiety in various settings such as hospitals and surgery centers across the United States. Founded in 2013 and based in Los Angeles, the company has established partnerships with leading healthcare institutions, including Cedars-Sinai and Children's Hospital Los Angeles. Its therapeutic virtual reality platform has been utilized by over 20,000 patients in more than 250 hospitals and in eight countries. The technology is designed to address both acute and chronic pain, as well as anxiety related to medical procedures, offering clinically validated, on-demand solutions. Inspired by extensive academic research, AppliedVR seeks to redefine pain management practices in clinical environments and at home, aiming to establish itself as a leading digital health solution provider in this field.

Magnus Medical

Series A in 2021
Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.

NextStep

Venture Round in 2021
NextStep Interactive, Inc. is a Seattle-based company that specializes in training and job placement services, particularly within the healthcare sector. Founded in 2018, the company offers a mobile and web-based platform designed to assess individuals' skills and interests, matching them with suitable career opportunities. Its services include a certified nursing assistant (CNA) training program and recruitment for entry-level healthcare positions, such as community health workers and home health aides. By enabling users to demonstrate competencies and soft skills, NextStep facilitates connections between job seekers and employers, streamlining the hiring process and helping individuals reskill affordably for in-demand roles. The company also has an office in Bozeman, Montana.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise. The company works with medical researchers and patient advocacy organizations to provide prescriptions to any patient using their mobile devices. Blue Note Therapeutics was founded in 2018 and is based in San Francisco, California.

AllStripes

Series B in 2021
AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare disease. AllStripes has developed a two-sided platform that empowers patients to access and benefit from their own medical records and generates regulatory-ready evidence for life sciences companies.

Swing Therapeutics

Seed Round in 2021
Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.

Mahana Therapeutics

Series B in 2021
Mahana Therapeutics, Inc. develops an application for treating patients suffering from gastrointestinal (GI) diseases and conditions. The company offers Parallel, a clinically-validated and minimal-contact digital program for people with irritable bowel syndrome (IBS). Mahana Therapeutics, Inc. was formerly known as Mahana Health, Inc. and changed its name to Mahana Therapeutics, Inc. in July 2019. The company was incorporated in 2018 and is based in San Francisco, California. It has an additional location in London, United Kingdom.

Woebot Health

Series B in 2021
Woebot Health develops digital mental health solutions aimed at making mental health support widely accessible. Founded in 2017 and headquartered in San Francisco, the company utilizes chatbot technology to provide personalized support for mood-based disorders. Its platform integrates natural language processing with established therapeutic techniques, creating engaging interactions that deliver tailored responses to users facing specific mental health challenges. This innovative approach allows individuals to access effective mental health support conveniently, fitting seamlessly into their daily lives. Woebot Health is backed by several venture capital firms, emphasizing its commitment to advancing mental health care through technology.

Thrive

Series C in 2021
Thrive Global provides behavior change programs aimed at improving well-being and productivity for both individuals and organizations. Founded by Arianna Huffington in 2016, the company is headquartered in New York and has an additional office in San Francisco. Thrive Global's mission is to combat stress and burnout through science-based solutions that enhance performance and promote healthier lifestyles. The company's approach includes corporate training and workshops that equip organizations with effective health and well-being strategies, a media platform that fosters discourse on well-being and performance, and an e-commerce section offering curated products for wellness. By integrating these components, Thrive Global empowers users to implement sustainable changes in their lives, facilitating a cultural shift toward more fulfilling and balanced living.

Zeitworks

Venture Round in 2021
Zeitworks Technologies, Inc. is a software-as-a-service (SaaS) company that specializes in business process improvement through an intelligent automation platform. Founded in 2020 and headquartered in Seattle, Washington, with an additional office in Los Angeles, California, the company utilizes machine learning to discover, analyze, and enhance business processes. Its platform operates without interrupting users or requiring system integrations, allowing it to measure and evaluate business process execution step-by-step based on the paths workers follow during their regular tasks. Currently, Zeitworks' solution is available to select pilot customers as the company develops its proprietary technology aimed at identifying opportunities for efficiency and improving customer experience.

Colossal Biosciences

Seed Round in 2021
Colossal Biosciences is an innovative firm in the field of bioscience and genetic engineering, focused on advancing genomics technology. The company is dedicated to developing transformative solutions for the restoration of extinct species, protection of critically endangered species, and the repopulation of essential ecosystems. Utilizing CRISPR technology, Colossal aims to facilitate species de-extinction, starting with the woolly mammoth, thereby enabling environmental organizations to rehabilitate ecosystems and promote biodiversity. Through its efforts, Colossal seeks to address ecological challenges while also considering the economic and biological needs of humanity.

AppliedVR

Series A in 2021
AppliedVR, Inc. specializes in virtual reality solutions aimed at enhancing patient experiences in healthcare, specifically for managing pain and anxiety in various settings such as hospitals and surgery centers across the United States. Founded in 2013 and based in Los Angeles, the company has established partnerships with leading healthcare institutions, including Cedars-Sinai and Children's Hospital Los Angeles. Its therapeutic virtual reality platform has been utilized by over 20,000 patients in more than 250 hospitals and in eight countries. The technology is designed to address both acute and chronic pain, as well as anxiety related to medical procedures, offering clinically validated, on-demand solutions. Inspired by extensive academic research, AppliedVR seeks to redefine pain management practices in clinical environments and at home, aiming to establish itself as a leading digital health solution provider in this field.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise. The company works with medical researchers and patient advocacy organizations to provide prescriptions to any patient using their mobile devices. Blue Note Therapeutics was founded in 2018 and is based in San Francisco, California.

Outside

Series B in 2021
Pocket Outdoor Media brands influence and engage more athletes than any other through a combined print, online, and social audience of millions of runners, cyclists, triathletes, and swimmers. It features bike racing media brand triathlete and Women’s Running focusing on resource for women runners;

RxREVU, Inc.

Series B in 2021
RxREVU, Inc. is a healthcare technology company based in Denver, Colorado, founded in 2013. It specializes in providing a medication savings dataset designed to enhance prescription decision support for healthcare applications, including transparency portals, insurance providers, and consumer mobile applications. The company's technology, which is integrated into electronic health records (EHR), enables prescribers to access real-time, patient-specific information about medication costs and alternatives, including therapeutic substitutions and generic options. This functionality supports healthcare professionals in identifying the most cost-effective medications at the point of care. RxREVU also offers prescription health analytics to help healthcare organizations understand prescribing behaviors and align those practices with established best practices. By collaborating with health systems and pharmacy benefit managers (PBMs), RxREVU aims to improve medication management and savings for both consumers and businesses.

NextStep

Venture Round in 2021
NextStep Interactive, Inc. is a Seattle-based company that specializes in training and job placement services, particularly within the healthcare sector. Founded in 2018, the company offers a mobile and web-based platform designed to assess individuals' skills and interests, matching them with suitable career opportunities. Its services include a certified nursing assistant (CNA) training program and recruitment for entry-level healthcare positions, such as community health workers and home health aides. By enabling users to demonstrate competencies and soft skills, NextStep facilitates connections between job seekers and employers, streamlining the hiring process and helping individuals reskill affordably for in-demand roles. The company also has an office in Bozeman, Montana.

Magnus Medical

Series A in 2020
Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.

Pear Therapeutics

Series D in 2020
Pear Therapeutics, Inc. focuses on developing and delivering clinically validated software-based therapeutics aimed at treating behavioral health disorders, including psychiatric and neurologic conditions. The company creates digital therapies for severe conditions such as addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and chronic insomnia. Its key products include mobile digital therapies that incentivize patients for completing treatment modules, reSET for substance use disorder, reSET-O for opioid use disorder, and Somryst for insomnia. Additionally, Pear Therapeutics offers PearConnect, a comprehensive patient services center that provides support for patients throughout their treatment journey, connects healthcare providers to resources, and assists insurance companies with claims processing. Founded in 2013, Pear Therapeutics is headquartered in Boston, Massachusetts, with an additional office in San Francisco, California.

Genesis Therapeutic

Series A in 2020
Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction. The company was founded in 2019 and based in South San Francisco, California.

Robust.AI

Series A in 2020
Robust.AI, Inc., founded in 2019 and based in Palo Alto, California, develops an industrial-grade cognitive platform designed to enhance robotic capabilities through common sense reasoning. The company aims to address various robotics challenges and promote the widespread adoption of mobile robots across multiple industries. Its platform integrates hybrid technology with AI that emphasizes common sense, resulting in robots that are intelligent, resilient, safe, and genuinely autonomous. By combining embodied AI, robotics, and human-centered design, Robust.AI produces Collaborative Mobile Robots that are context-aware and user-friendly, facilitating easy installation and adoption for businesses.

Freeletics

Series B in 2020
Freeletics GmbH is a digital fitness company based in Munich, Germany, founded in 2013. It specializes in developing and operating a fitness application that provides personalized AI-driven coaching for physical fitness and mental well-being. The app offers a variety of features, including tailored training programs, nutrition coaching, and real-time health assessments, enabling users to train effectively without the need for equipment or gym access. By focusing on both physical fitness and mental strength, Freeletics aims to empower individuals to reach their personal fitness goals and enhance their overall lifestyle. The company promotes a holistic approach to health, emphasizing the importance of willpower, confidence, and the potential for self-improvement.

Outside

Series A in 2020
Pocket Outdoor Media brands influence and engage more athletes than any other through a combined print, online, and social audience of millions of runners, cyclists, triathletes, and swimmers. It features bike racing media brand triathlete and Women’s Running focusing on resource for women runners;

Zeitworks

Seed Round in 2020
Zeitworks Technologies, Inc. is a software-as-a-service (SaaS) company that specializes in business process improvement through an intelligent automation platform. Founded in 2020 and headquartered in Seattle, Washington, with an additional office in Los Angeles, California, the company utilizes machine learning to discover, analyze, and enhance business processes. Its platform operates without interrupting users or requiring system integrations, allowing it to measure and evaluate business process execution step-by-step based on the paths workers follow during their regular tasks. Currently, Zeitworks' solution is available to select pilot customers as the company develops its proprietary technology aimed at identifying opportunities for efficiency and improving customer experience.

The Meta

Series A in 2020
The Meta Game Inc. is a company focused on developing training tools for first-person shooter (FPS) gamers, enhancing their skills across all levels. Its primary product, KovaaK, features a range of capabilities including realistic weapon simulation, target and dodging physics, and customizable training scenarios tailored to individual user profiles. The company integrates principles from performance science, game development, and machine learning to create effective training modules that help gamers refine their tactics and improve their gameplay. Founded in 2017 and based in San Francisco, California, The Meta Game Inc. aims to advance the eSports training landscape.

Mahana Therapeutics

Series A in 2020
Mahana Therapeutics, Inc. develops an application for treating patients suffering from gastrointestinal (GI) diseases and conditions. The company offers Parallel, a clinically-validated and minimal-contact digital program for people with irritable bowel syndrome (IBS). Mahana Therapeutics, Inc. was formerly known as Mahana Health, Inc. and changed its name to Mahana Therapeutics, Inc. in July 2019. The company was incorporated in 2018 and is based in San Francisco, California. It has an additional location in London, United Kingdom.

NextStep

Venture Round in 2020
NextStep Interactive, Inc. is a Seattle-based company that specializes in training and job placement services, particularly within the healthcare sector. Founded in 2018, the company offers a mobile and web-based platform designed to assess individuals' skills and interests, matching them with suitable career opportunities. Its services include a certified nursing assistant (CNA) training program and recruitment for entry-level healthcare positions, such as community health workers and home health aides. By enabling users to demonstrate competencies and soft skills, NextStep facilitates connections between job seekers and employers, streamlining the hiring process and helping individuals reskill affordably for in-demand roles. The company also has an office in Bozeman, Montana.

Mahana Therapeutics

Seed Round in 2020
Mahana Therapeutics, Inc. develops an application for treating patients suffering from gastrointestinal (GI) diseases and conditions. The company offers Parallel, a clinically-validated and minimal-contact digital program for people with irritable bowel syndrome (IBS). Mahana Therapeutics, Inc. was formerly known as Mahana Health, Inc. and changed its name to Mahana Therapeutics, Inc. in July 2019. The company was incorporated in 2018 and is based in San Francisco, California. It has an additional location in London, United Kingdom.

Cadence Neuroscience

Series A in 2019
Cadence Neuroscience, Inc. is an early-stage company based in Redmond, Washington, specializing in the development of innovative medical device therapies for neurological disorders, including epilepsy and central pain. Founded in 2017, the company has developed its core technology at the Mayo Clinic, which is currently undergoing clinical evaluation. Cadence Neuroscience's implantable devices are designed to detect specific brain signals and deliver targeted electrical stimulation, allowing for tailored brain stimulation therapies that aim to enhance seizure control and improve treatment outcomes compared to existing protocols.

NextStep

Series A in 2019
NextStep Interactive, Inc. is a Seattle-based company that specializes in training and job placement services, particularly within the healthcare sector. Founded in 2018, the company offers a mobile and web-based platform designed to assess individuals' skills and interests, matching them with suitable career opportunities. Its services include a certified nursing assistant (CNA) training program and recruitment for entry-level healthcare positions, such as community health workers and home health aides. By enabling users to demonstrate competencies and soft skills, NextStep facilitates connections between job seekers and employers, streamlining the hiring process and helping individuals reskill affordably for in-demand roles. The company also has an office in Bozeman, Montana.

RxREVU, Inc.

Series A in 2019
RxREVU, Inc. is a healthcare technology company based in Denver, Colorado, founded in 2013. It specializes in providing a medication savings dataset designed to enhance prescription decision support for healthcare applications, including transparency portals, insurance providers, and consumer mobile applications. The company's technology, which is integrated into electronic health records (EHR), enables prescribers to access real-time, patient-specific information about medication costs and alternatives, including therapeutic substitutions and generic options. This functionality supports healthcare professionals in identifying the most cost-effective medications at the point of care. RxREVU also offers prescription health analytics to help healthcare organizations understand prescribing behaviors and align those practices with established best practices. By collaborating with health systems and pharmacy benefit managers (PBMs), RxREVU aims to improve medication management and savings for both consumers and businesses.

Wade & Wendy

Series A in 2019
Wade & Wendy, Inc. is a New York-based company that specializes in developing software to enhance the hiring process through artificial intelligence. Founded in June 2015, the company offers two main products: Wendy, a chatbot designed for employers that screens job applicants and provides recommendations, and Wade, a chatbot for job seekers that utilizes AI to collect data and match users with suitable job opportunities. By leveraging machine intelligence, Wade & Wendy aims to create a more human and engaging experience for both hiring teams and candidates, facilitating better connections and informed hiring decisions.

Pear Therapeutics

Series C in 2019
Pear Therapeutics, Inc. focuses on developing and delivering clinically validated software-based therapeutics aimed at treating behavioral health disorders, including psychiatric and neurologic conditions. The company creates digital therapies for severe conditions such as addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and chronic insomnia. Its key products include mobile digital therapies that incentivize patients for completing treatment modules, reSET for substance use disorder, reSET-O for opioid use disorder, and Somryst for insomnia. Additionally, Pear Therapeutics offers PearConnect, a comprehensive patient services center that provides support for patients throughout their treatment journey, connects healthcare providers to resources, and assists insurance companies with claims processing. Founded in 2013, Pear Therapeutics is headquartered in Boston, Massachusetts, with an additional office in San Francisco, California.

AI Redefined

Seed Round in 2018
AI Redefined is a software company focused on advancing machine learning research and applications. The company aims to enhance the interaction between humans and artificial intelligence by creating a universal and secure digital environment for continuous learning. Its flagship product, Cogment, is an open-source framework designed for the simultaneous live training of both AIs and humans within the same setting. This platform provides various tools and infrastructure, including operator AI apprentices and adaptive learning features, facilitating seamless human-AI collaboration. By emphasizing adaptive training and fine-tuning, AI Redefined enables clients to establish effective partnerships between technology and people, fostering innovation and improving overall outcomes.

Freeletics

Series A in 2018
Freeletics GmbH is a digital fitness company based in Munich, Germany, founded in 2013. It specializes in developing and operating a fitness application that provides personalized AI-driven coaching for physical fitness and mental well-being. The app offers a variety of features, including tailored training programs, nutrition coaching, and real-time health assessments, enabling users to train effectively without the need for equipment or gym access. By focusing on both physical fitness and mental strength, Freeletics aims to empower individuals to reach their personal fitness goals and enhance their overall lifestyle. The company promotes a holistic approach to health, emphasizing the importance of willpower, confidence, and the potential for self-improvement.

Freeletics

Series A in 2018
Freeletics GmbH is a digital fitness company based in Munich, Germany, founded in 2013. It specializes in developing and operating a fitness application that provides personalized AI-driven coaching for physical fitness and mental well-being. The app offers a variety of features, including tailored training programs, nutrition coaching, and real-time health assessments, enabling users to train effectively without the need for equipment or gym access. By focusing on both physical fitness and mental strength, Freeletics aims to empower individuals to reach their personal fitness goals and enhance their overall lifestyle. The company promotes a holistic approach to health, emphasizing the importance of willpower, confidence, and the potential for self-improvement.

NextStep

Seed Round in 2018
NextStep Interactive, Inc. is a Seattle-based company that specializes in training and job placement services, particularly within the healthcare sector. Founded in 2018, the company offers a mobile and web-based platform designed to assess individuals' skills and interests, matching them with suitable career opportunities. Its services include a certified nursing assistant (CNA) training program and recruitment for entry-level healthcare positions, such as community health workers and home health aides. By enabling users to demonstrate competencies and soft skills, NextStep facilitates connections between job seekers and employers, streamlining the hiring process and helping individuals reskill affordably for in-demand roles. The company also has an office in Bozeman, Montana.

Perceptive Automata

Series A in 2018
Perceptive Automata, Inc. specializes in machine learning and computer vision technologies aimed at predicting human behavior to enhance the safety and efficacy of automated vehicles. Founded in 2014 and headquartered in Somerville, Massachusetts, the company addresses a critical challenge in automated driving: enabling vehicles to anticipate the actions of pedestrians, cyclists, and other drivers. This capability is vital for the smooth and safe operation of highly automated (L2/3) and fully autonomous (L4/5) vehicles, particularly in urban environments. By leveraging advanced AI that surpasses conventional physics-based models, Perceptive Automata facilitates a more natural driving experience and promotes the acceptance of autonomous vehicles in human-dominated road scenarios. The company collaborates with original equipment manufacturers, suppliers, and technology firms involved in the development of advanced driver-assistance systems and autonomous driving solutions, drawing on a team of experts from esteemed institutions such as Harvard, MIT, and Stanford.

Pymetrics

Series B in 2018
Pymetrics, Inc. is a company that specializes in developing neuroscience-based assessment and prediction technology aimed at transforming the recruitment, retention, and development of employees. Founded in 2013 and headquartered in New York City, Pymetrics utilizes a combination of neuroscience and machine learning to create a talent matching platform. This platform collects behavioral data from successful professionals across various roles to identify key traits that distinguish top performers from the general population. By offering cognitive and emotional assessment solutions, along with a personalized recommendation engine, Pymetrics enhances the effectiveness and accuracy of the hiring process, while promoting unbiased recruitment practices.

Freeletics

Venture Round in 2018
Freeletics GmbH is a digital fitness company based in Munich, Germany, founded in 2013. It specializes in developing and operating a fitness application that provides personalized AI-driven coaching for physical fitness and mental well-being. The app offers a variety of features, including tailored training programs, nutrition coaching, and real-time health assessments, enabling users to train effectively without the need for equipment or gym access. By focusing on both physical fitness and mental strength, Freeletics aims to empower individuals to reach their personal fitness goals and enhance their overall lifestyle. The company promotes a holistic approach to health, emphasizing the importance of willpower, confidence, and the potential for self-improvement.

Embodied

Series A in 2018
Embodied is an AI company that develops state-of-the-art companion robots that aim to revolutionize care and wellness, enhancing the quality of life for individuals and families. They are combining 14 years of research in socially assistive robotics from the University of Southern California with 15 years of experience with commercialization of consumer robotics from iRobot, and decades of animation and storytelling to build life-like, interactive robots to serve as motivators, coaches, and companions that help and empower people to be better at helping themselves.

Mediscope

Convertible Note in 2018
Wisdo Ltd. is a social health platform focused on combating the loneliness epidemic that affects a significant portion of the population. Established in 2015 and headquartered in Israel, Wisdo utilizes an AI-powered system to facilitate meaningful connections among users dealing with mental health challenges and various illnesses. The platform allows individuals to share their experiences, engage in discussions, and receive support from others who have faced similar situations. By fostering a sense of community, Wisdo aims to improve users' social, emotional, and physical well-being while addressing the detrimental effects of social isolation. With over 1.4 million members, the platform encourages users to document their journeys, set personal goals, and monitor their progress toward achieving happiness and fulfillment.

Thrive

Series B in 2018
Thrive Global provides behavior change programs aimed at improving well-being and productivity for both individuals and organizations. Founded by Arianna Huffington in 2016, the company is headquartered in New York and has an additional office in San Francisco. Thrive Global's mission is to combat stress and burnout through science-based solutions that enhance performance and promote healthier lifestyles. The company's approach includes corporate training and workshops that equip organizations with effective health and well-being strategies, a media platform that fosters discourse on well-being and performance, and an e-commerce section offering curated products for wellness. By integrating these components, Thrive Global empowers users to implement sustainable changes in their lives, facilitating a cultural shift toward more fulfilling and balanced living.

Akili Interactive

Series C in 2018
Akili Interactive Labs, Inc. is a digital medicine company based in Boston, Massachusetts, that develops innovative platform technology to enhance cognitive abilities through video game-like experiences. Incorporated in 2011, the company focuses on creating clinically validated cognitive therapeutics, assessments, and diagnostics that can be prescribed and monitored by physicians remotely. Akili's cognitive engine supports multiple clinical game versions designed for patient engagement and remote data capture. Its proprietary adaptive mechanics allow the software to personalize to each patient's ability level automatically, without requiring clinician input. This approach aims to provide a cost-effective alternative to traditional medical treatments, making advanced cognitive therapies accessible to patients regardless of their location.

Woebot Health

Series A in 2018
Woebot Health develops digital mental health solutions aimed at making mental health support widely accessible. Founded in 2017 and headquartered in San Francisco, the company utilizes chatbot technology to provide personalized support for mood-based disorders. Its platform integrates natural language processing with established therapeutic techniques, creating engaging interactions that deliver tailored responses to users facing specific mental health challenges. This innovative approach allows individuals to access effective mental health support conveniently, fitting seamlessly into their daily lives. Woebot Health is backed by several venture capital firms, emphasizing its commitment to advancing mental health care through technology.

Halo Neuroscience

Series B in 2018
Halo Neuroscience is a neurotechnology company based in San Francisco that focuses on enhancing human performance through innovative systems. Since its incorporation in 2013, the company has developed its flagship product, Halo Sport, which employs Neuropriming technology. This technology involves delivering electrical stimulation during physical training to enhance the brain's learning capacity, a state referred to as "hyperplasticity." By improving the connections between the brain and muscles, Halo Sport aims to accelerate skill acquisition and strength development, particularly for elite athletes. Through its advancements in neurotechnology, Halo Neuroscience seeks to help individuals maximize their potential in various performance domains.

Pear Therapeutics

Series B in 2018
Pear Therapeutics, Inc. focuses on developing and delivering clinically validated software-based therapeutics aimed at treating behavioral health disorders, including psychiatric and neurologic conditions. The company creates digital therapies for severe conditions such as addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and chronic insomnia. Its key products include mobile digital therapies that incentivize patients for completing treatment modules, reSET for substance use disorder, reSET-O for opioid use disorder, and Somryst for insomnia. Additionally, Pear Therapeutics offers PearConnect, a comprehensive patient services center that provides support for patients throughout their treatment journey, connects healthcare providers to resources, and assists insurance companies with claims processing. Founded in 2013, Pear Therapeutics is headquartered in Boston, Massachusetts, with an additional office in San Francisco, California.

Level Ex

Series A in 2017
Level Ex, Inc. is a Chicago-based company that specializes in developing virtual surgery mobile applications aimed at enhancing the skills of physicians in performing minimally invasive procedures. Its flagship product, Airway EX, serves as a training tool for mastering critical skills related to endoscopic and interventional airway procedures, addressing a variety of complex medical scenarios. Additionally, Level Ex offers Virtual Technique Guides, a surgical training platform that incorporates multiplayer interactivity, enabling surgeons to practice virtual procedures alongside medical device sales representatives in a web conferencing environment. By leveraging advanced video game technology and cognitive neuroscience, Level Ex provides a dynamic and engaging way for healthcare professionals to stay current with rare medical cases, new devices, and emerging therapies. Founded in 2015, the company focuses on improving medical training and performance through innovative digital solutions.

Pymetrics

Series A in 2017
Pymetrics, Inc. is a company that specializes in developing neuroscience-based assessment and prediction technology aimed at transforming the recruitment, retention, and development of employees. Founded in 2013 and headquartered in New York City, Pymetrics utilizes a combination of neuroscience and machine learning to create a talent matching platform. This platform collects behavioral data from successful professionals across various roles to identify key traits that distinguish top performers from the general population. By offering cognitive and emotional assessment solutions, along with a personalized recommendation engine, Pymetrics enhances the effectiveness and accuracy of the hiring process, while promoting unbiased recruitment practices.

Augment CXM

Seed Round in 2017
Augment CXM is a San Francisco-based company founded in 2017 that specializes in developing a customer experience platform powered by artificial intelligence. The company utilizes a patented semantic neural network to enhance customer service delivery, enabling brand representatives to interact more effectively with customers through machine learning-based live chat and messaging applications. Augment CXM also offers an application called Product Helper, which integrates with existing product inventory management systems to provide agents with suggested products based on customer inquiries. The company's innovative solutions have demonstrated significant results, including a 30% increase in agent efficiency, a 44% rise in sales conversion rates, and a 40% improvement in customer satisfaction for its clients, which include some of the most recognized brands globally.

Aira

Series B in 2017
Aira Tech Corp. is a company that offers an online platform designed to assist blind and low-vision individuals by providing remote visual interpretation services. Established in 2015 and based in La Jolla, California, Aira connects users with trained agents through a combination of wearable smart glasses and a smartphone app. When users activate the service, their phone's camera streams live video to a network of certified Visual Interpreters, who offer real-time assistance for various daily tasks. This technology enables users to navigate their environments, recognize faces, and engage in activities with increased mobility and independence. Aira's mission is to enhance accessibility for the visually impaired, allowing them to experience the world more fully and independently.

Two Bit Circus

Series B in 2017
Two Bit Circus, Inc. is an entertainment company that invents and installs out-of-home physical amusement circus in California. It also offers Park as a Platform program to enable game developers to create location-based entertainment. The company features games, interactive amusement, stage shows, aerialists, food, and more. It also sells T-shirts, stickers, and clown noses online. The company was founded in 2012 and is headquartered in Los Angeles, California.

Halo Neuroscience

Series A in 2016
Halo Neuroscience is a neurotechnology company based in San Francisco that focuses on enhancing human performance through innovative systems. Since its incorporation in 2013, the company has developed its flagship product, Halo Sport, which employs Neuropriming technology. This technology involves delivering electrical stimulation during physical training to enhance the brain's learning capacity, a state referred to as "hyperplasticity." By improving the connections between the brain and muscles, Halo Sport aims to accelerate skill acquisition and strength development, particularly for elite athletes. Through its advancements in neurotechnology, Halo Neuroscience seeks to help individuals maximize their potential in various performance domains.

Pear Therapeutics

Series A in 2016
Pear Therapeutics, Inc. focuses on developing and delivering clinically validated software-based therapeutics aimed at treating behavioral health disorders, including psychiatric and neurologic conditions. The company creates digital therapies for severe conditions such as addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and chronic insomnia. Its key products include mobile digital therapies that incentivize patients for completing treatment modules, reSET for substance use disorder, reSET-O for opioid use disorder, and Somryst for insomnia. Additionally, Pear Therapeutics offers PearConnect, a comprehensive patient services center that provides support for patients throughout their treatment journey, connects healthcare providers to resources, and assists insurance companies with claims processing. Founded in 2013, Pear Therapeutics is headquartered in Boston, Massachusetts, with an additional office in San Francisco, California.

Akili Interactive

Series B in 2016
Akili Interactive Labs, Inc. is a digital medicine company based in Boston, Massachusetts, that develops innovative platform technology to enhance cognitive abilities through video game-like experiences. Incorporated in 2011, the company focuses on creating clinically validated cognitive therapeutics, assessments, and diagnostics that can be prescribed and monitored by physicians remotely. Akili's cognitive engine supports multiple clinical game versions designed for patient engagement and remote data capture. Its proprietary adaptive mechanics allow the software to personalize to each patient's ability level automatically, without requiring clinician input. This approach aims to provide a cost-effective alternative to traditional medical treatments, making advanced cognitive therapies accessible to patients regardless of their location.

Level Ex

Seed Round in 2016
Level Ex, Inc. is a Chicago-based company that specializes in developing virtual surgery mobile applications aimed at enhancing the skills of physicians in performing minimally invasive procedures. Its flagship product, Airway EX, serves as a training tool for mastering critical skills related to endoscopic and interventional airway procedures, addressing a variety of complex medical scenarios. Additionally, Level Ex offers Virtual Technique Guides, a surgical training platform that incorporates multiplayer interactivity, enabling surgeons to practice virtual procedures alongside medical device sales representatives in a web conferencing environment. By leveraging advanced video game technology and cognitive neuroscience, Level Ex provides a dynamic and engaging way for healthcare professionals to stay current with rare medical cases, new devices, and emerging therapies. Founded in 2015, the company focuses on improving medical training and performance through innovative digital solutions.

Eyefluence

Series B in 2015
Eyefluence, Inc. specializes in developing eye-interaction technology that enables control of augmented reality (AR), virtual reality (VR), and mixed reality (MR) head-mounted displays (HMDs) using eye movements. Founded in 2013 and headquartered in Reno, Nevada, the company combines insights from eye biomechanics and the eye-brain connection to create the fastest interface for HMDs. Eyefluence serves manufacturers in the AR, VR, and MR sectors, focusing on enhancing human communication and interaction within these immersive environments. The company is led by experienced entrepreneurs Jim Marggraff and David Stiehr and boasts a multidisciplinary team of experts in various fields, including optics, engineering, and artificial intelligence. Eyefluence holds a robust intellectual property portfolio with over 30 patents, reflecting its commitment to innovation. The company collaborates with emerging startups and established Fortune 100 firms to promote the adoption of smart glasses for various applications across enterprise, industrial, government, and consumer markets. As of October 2016, Eyefluence operates as a subsidiary of Google Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.